📖

TREM2-Targeting Therapies

wiki page Created: 2026-04-02 13:40:08 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-therapeutics-trem2-targeting-therap
Related Entities
therapeutics-trem2-targeting-therapies
Metadata
slugtherapeutics-trem2-targeting-therapies
entity_typetherapeutic
kg_node_idNone
Linked Artifacts (232)
mentions🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Bacterial Enzyme-Mediated Dopamine Precursor Synthesis90%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia90%
mentions🧫Microglial TREM2 Agonist In Vivo Efficacy80%
mentions🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim80%
mentions🧫TREM2 Function in Alzheimer's Disease — From Risk Varia80%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination80%
mentions🧪TREM2-mediated microglial tau clearance enhancement80%
mentions🔬Immune atlas neuroinflammation analysis in neurodegeneration75%
mentions🔬Neuroinflammation and microglial priming in early Alzheimer&75%
mentions🔬Neuroinflammation and microglial priming in early AD — Analy75%
mentions🔬Does SYK activation provide neuroprotection or exacerbate ne75%
mentions🔬What are the optimal timing windows for TREM2 agonism vs ant75%
mentions🔬Analysis question not specified75%
related🧫Microglial TREM2 Agonist In Vivo Efficacy72%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim72%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia72%
mentions🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia70%
mentions🧫s:** - GPR32 knockout in microglia should worsen neuroinflam70%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro70%
mentions🧫Proposed experiment from debate on Synaptic pruning by micro70%
mentions🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional70%
mentions🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti70%
mentions🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy70%
mentions🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri70%
mentions🧫Experiment: Autoimmune Hypothesis Testing in AD70%
mentions🧫Blood Biomarker vs Tau PET for Treatment Monitoring70%
mentions🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi70%
mentions🧫DLB Cognitive Fluctuation Mechanism Experiment70%
mentions🧫Genetic Risk Modifiers in DLB Phenotype70%
mentions🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras70%
mentions🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud70%
mentions🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation70%
mentions🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr70%
mentions🧫Microglial Contributions to Huntington's Disease Pathog70%
mentions🧫Mixed Pathology Effects on Parkinson's Disease Progress70%
mentions🧫Prodromal Parkinson's Disease Biomarker Development — E70%
mentions🧫Progranulin Replacement Therapy for FTD — Vector Development70%
mentions🧫PSP and CBS Biomarker Validation Study70%
mentions🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo70%
mentions🧫Experiment Validation: In vitro ThT Assay70%
mentions🧫Tau ASO Therapy70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧫TREM2 KO amyloid pathology study70%
mentions🧪TREM2-mediated microglial tau clearance enhancement70%
related🧪Trinucleotide Repeat Sequestration via CRISPR-Guided RNA Tar70%
related🧪Targeting Bacterial Curli Fibrils to Prevent α-Synuclein Cro70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination70%
related🧪APOE-TREM2 Interaction Modulation70%
related🧪TREM2-Mediated Selective Aggregate Clearance Pathway70%
related🧪TREM2-Dependent Microglial Senescence Transition70%
related🧪TREM2-mediated microglial tau clearance enhancement70%
related🧪Cell-Type Specific TREM2 Upregulation in DAM Microglia70%
related🧫ER-Golgi Secretory Pathway Dysfunction in PD - Experiment De70%
related🧫Non-Motor Symptom Progression in Parkinson's Disease — 70%
related🧫Microglial TREM2 Agonist In Vivo Efficacy70%
related🧫TREM2 Agonist Therapy for Parkinson's Disease — Experim70%
related🧫TREM2 Function in Alzheimer's Disease — From Risk Varia70%
mentions🧪Microbial Inflammasome Priming Prevention69%
mentions🧪Targeted APOE4-to-APOE3 Base Editing Therapy67%
related🔬Immune atlas neuroinflammation analysis in neurodegeneration67%
related🔬Neuroinflammation and microglial priming in early Alzheimer&67%
related🔬Neuroinflammation and microglial priming in early AD — Analy67%
related🔬Does SYK activation provide neuroprotection or exacerbate ne67%
related🔬What are the optimal timing windows for TREM2 agonism vs ant67%
related🔬Analysis question not specified67%
mentions🧪APOE4 Allosteric Rescue via Small Molecule Chaperones67%
mentions🧪TREM2 Conformational Stabilizers for Synaptic Discrimination65%
mentions🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer65%
mentions🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides65%
mentions🧪Competitive APOE4 Domain Stabilization Peptides64%
mentions🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction63%
related🧫s:** - GPR32 knockout in microglia should worsen neuroinflam63%
related🧫Proposed experiment from debate on Synaptic pruning by micro63%
related🧫Proposed experiment from debate on Synaptic pruning by micro63%
related🧫s:** - Compare tau strain spreading in EXT1/EXT2 conditional63%
related🧫Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti63%
related🧫Anti-Tau Antibody vs ASO/Gene Therapy — Comparative Efficacy63%
related🧫Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri63%
related🧫Experiment: Autoimmune Hypothesis Testing in AD63%
related🧫Blood Biomarker vs Tau PET for Treatment Monitoring63%
related🧫CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi63%
related🧫DLB Cognitive Fluctuation Mechanism Experiment63%
related🧫Genetic Risk Modifiers in DLB Phenotype63%
related🧫DLB Treatment Response Biomarkers — Predicting Cholinesteras63%
related🧫FTD Microglia Role: Protective vs Destructive Mechanism Stud63%
related🧫FTLD-Tau vs FTLD-TDP In Vivo Biomarker Differentiation63%
related🧫Microglial Aging and Immune Memory in Neurodegeneration — Tr63%
related🧫Microglial Contributions to Huntington's Disease Pathog63%
related🧫Mixed Pathology Effects on Parkinson's Disease Progress63%
related🧫Prodromal Parkinson's Disease Biomarker Development — E63%
related🧫Progranulin Replacement Therapy for FTD — Vector Development63%
related🧫PSP and CBS Biomarker Validation Study63%
related🧫Tau PET Pattern as Therapeutic Response Predictor in 4R-Tauo63%
related🧫Experiment Validation: In vitro ThT Assay63%
related🧫Tau ASO Therapy63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧫TREM2 KO amyloid pathology study63%
related🧪TREM2-mediated microglial tau clearance enhancement63%
related🧪Microbial Inflammasome Priming Prevention62%
related🧪Targeted APOE4-to-APOE3 Base Editing Therapy60%
related🧪APOE4 Allosteric Rescue via Small Molecule Chaperones60%
mentions🧪APOE-TREM2 Interaction Modulation60%
mentions🧪TREM2-Mediated Selective Aggregate Clearance Pathway60%
mentions🧪TREM2-Dependent Microglial Senescence Transition60%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR60%
mentions🔬The disease-associated microglia (DAM) phenotype involves TR60%
mentions🔬Comprehensive analysis of immune cell subtypes in neurodegen60%
related🔬What are the mechanisms underlying protein aggregation cross60%
related🔬What are the mechanisms underlying mechanistic role of apoe 60%
related🔬What are the mechanisms underlying synaptic pruning by micro60%
related🔬What gene expression changes in the aging mouse brain predic60%
related🔬Investigate prion-like spreading of tau pathology through co60%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas60%
related🧪TREM2 Conformational Stabilizers for Synaptic Discrimination59%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer59%
related🧪Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides59%
related🧪Competitive APOE4 Domain Stabilization Peptides57%
related🧪Interfacial Lipid Mimetics to Disrupt Domain Interaction56%
related🧪APOE-TREM2 Interaction Modulation54%
related🧪TREM2-Mediated Selective Aggregate Clearance Pathway54%
related🧪TREM2-Dependent Microglial Senescence Transition54%
related🔬The disease-associated microglia (DAM) phenotype involves TR54%
related🔬The disease-associated microglia (DAM) phenotype involves TR54%
related🔬Comprehensive analysis of immune cell subtypes in neurodegen54%
mentions🧫AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi50%
mentions🧫AD Combination Therapy Trial: Anti-Aβ + Anti-Tau50%
mentions🧫Sex Differences in Alzheimer's Disease — mechanisms and50%
mentions🧪APOE Isoform Conversion Therapy50%
mentions🧪APOE4-Selective Lipid Nanoemulsion Therapy50%
mentions🧪APOE Isoform Expression Across Glial Subtypes50%
mentions🧪DNMT1-Targeting Antisense Oligonucleotide Reset50%
mentions🧪Metabolic Switch Targeting for A1→A2 Repolarization50%
mentions🧪Phase-Separated Organelle Targeting50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying synaptic pruning by micro50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬Investigate prion-like spreading of tau pathology through co50%
related🔬SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas50%
related🔬What are the mechanisms underlying tdp-43 phase separation t50%
related🔬What are the mechanisms underlying astrocyte reactivity subt50%
related🔬What are the mechanisms underlying blood-brain barrier trans50%
related🔬What are the mechanisms underlying microglia-astrocyte cross50%
related🔬What are the mechanisms underlying apoe4 structural biology 50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying epigenetic clocks and bio50%
related🔬What are the most promising therapeutic strategies for targe50%
related🔬TDP-43 undergoes liquid-liquid phase separation that becomes50%
related🔬Senolytics targeting p16/p21+ senescent astrocytes and micro50%
related🧪Pericyte Contractility Reset via Selective PDGFR-β Agonism50%
related🧪Magnetosonic-Triggered Transferrin Receptor Clustering50%
related🔬What are the mechanisms underlying what are the mechanisms b50%
related🔬What are the mechanisms underlying protein aggregation cross50%
related🔬What are the mechanisms underlying mechanistic role of apoe 50%
see_also📖sTREM2 (Soluble TREM2) - Microglial Biomarker50%
see_also📖sTREM2 (Soluble TREM2) - Biomarker50%
see_also📖al002-trem2-agonist-alzheimers50%
see_also📖TREM2 Gene50%
see_also📖TREM2 Gene-Mechanism-Therapy Chain — From Genetic Risk to Th50%
see_also📖Adipose-Derived Mesenchymal Stem Cell Therapy for Early Alzh45%
see_also📖Cannabidiol for Alzheimer's Disease Prevention (NCT058245%
see_also📖EX039 Phase 2 (NCT05413655) — Oral Therapeutic for Alzheimer45%
see_also📖LEAF Trial - THC+CBD for Alzheimer's Disease Agitation 45%
see_also📖Synaptic Therapy Alzheimer's Research Trial (START): A 45%
see_also📖The Alzheimer's Disease Tau Platform Clinical Trial (NC45%
see_also📖A Phase 3, Randomised, Double-blinded, Placebo-controlled St45%
see_also📖Master Screening Study to Determine Individuals With Potenti45%
see_also📖NCT07262645: Near-Infrared Light Therapy for Mild-Moderate A45%
see_also📖Rotigotine and Rivastigmine Combination Therapy for Alzheime45%
see_also📖SToP-AD: Suvorexant for Alzheimer's Disease Prevention45%
see_also📖Antibody Therapy in Neurodegeneration45%
see_also📖APOE Lipid Metabolism Pathway in Alzheimer's Disease45%
see_also📖Axon Guidance Pathways in Neurodegeneration45%
see_also📖Convergent Pathways in Neurodegeneration45%
see_also📖COVID-19 Neurodegeneration Mechanism45%
see_also📖Down Syndrome Neurodegeneration Pathway45%
see_also📖Dystrophic Neurites in Neurodegeneration45%
see_also📖Endolysosomal Pathway in Alzheimer's Disease45%
see_also📖Endosomal-Lysosomal Pathway in Neurodegeneration45%
see_also📖Galectin-3 Mechanism in Neurodegeneration45%
see_also📖Geniposide for Alzheimer's disease - immune biomarker t45%
see_also📖gp130/IL-6 Family Cytokine Signaling in Neurodegeneration45%
see_also📖HMGB1 Signaling in Neurodegeneration45%
see_also📖IL-1 Signaling Pathway in Neurodegeneration45%
see_also📖Lipid Metabolism Dysregulation in Neurodegeneration45%
see_also📖Microglial Priming Pathway in Neurodegeneration45%
see_also📖Mitochondrial Dysfunction in Alzheimer's Disease Pathwa45%
see_also📖Neuroinflammation Hypothesis in Alzheimer's Disease45%
see_also📖Neurovascular Dysfunction in Alzheimer's Disease: Integ45%
see_also📖NLRP3 Inflammasome Pathway in Alzheimer's Disease45%
see_also📖Retinal Degeneration Pathway in Neurodegeneration45%
see_also📖Senescent Cell Clearance in Neurodegeneration45%
see_also📖Sex Differences in Neurodegeneration45%
see_also📖Sporadic Alzheimer's Disease Pathway45%
see_also📖Synaptic Loss in Alzheimer's Disease Pathway45%
see_also📖Tau Seeding and Propagation Pathway45%
see_also📖Therapeutic Targets in Neurodegeneration45%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%
see_also📖Transdiagnostic Proteomic Changes in Neurodegeneration45%
see_also📖TREM2 in Amyotrophic Lateral Sclerosis45%
see_also📖TREM2 in Frontotemporal Dementia45%
see_also📖Vascular Dementia Mechanisms — Overlap with Alzheimer's45%
mentions🧫CRISPR Gene Correction Approaches for CBS/PSP44%
mentions🔬What are the mechanisms underlying apoe4 structural biology 40%
mentions🔬What are the most promising therapeutic strategies for targe40%
mentions🔬TDP-43 undergoes liquid-liquid phase separation that becomes40%
mentions🔬Senolytics targeting p16/p21+ senescent astrocytes and micro40%
mentions🔬What are the mechanisms underlying tdp-43 phase separation t40%
mentions🔬What are the mechanisms underlying blood-brain barrier trans40%
related🧪DNMT1-Targeting Antisense Oligonucleotide Reset40%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization40%
related🧪Phase-Separated Organelle Targeting40%
related🧪Selective APOE4 Degradation via Proteolysis Targeting Chimer35%
related🧪Proteostasis Enhancement via APOE Chaperone Targeting35%
related🧪Metabolic Switch Targeting for A1→A2 Repolarization35%
related🧪Phase-Separated Organelle Targeting35%